About Xbiome
Xbiome is a company based in Shenzhen (China) founded in 2017. Xbiome has raised $107.5 million across 5 funding rounds from investors including Primavera Capital Group, Gaorong Capital and Legend Capital. Xbiome operates in a competitive market with competitors including DNAnexus, Helix, Benchling, Cytel and Genuity Science, among others.
- Headquarter Shenzhen, China
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$107.5 M (USD)
in 5 rounds
-
Latest Funding Round
$100 M (USD), Series B
Dec 22, 2021
-
Investors
Primavera Capital Group
& 9 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Xbiome
Unlock access to complete
Funding Insights of Xbiome
Xbiome has successfully raised a total of $107.5M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $100 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $100.0M
-
First Round
First Round
(01 Aug 2018)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2021 | Amount | Series B - Xbiome | Valuation | Gaorong Capital | |
| Dec, 2020 | Amount | Series B - Xbiome | Valuation | Primavera , Gaorong Capital | |
| Nov, 2019 | Amount | Series B - Xbiome | Valuation | Legend Capital |
Investors in Xbiome
Xbiome has secured backing from 10 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Primavera Capital Group, Gaorong Capital and Legend Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early and growth-stage TMT startups are funded in China.
|
Founded Year | Domain | Location | |
|
Venture Capital firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Tech investments are made stage-agnostically in China and the US.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Xbiome
Financial Statements - Xbiome
Xbiome Comparisons
Competitors of Xbiome
Xbiome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, Helix, Benchling, Cytel and Genuity Science, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cloud-based genome informatics and data management are provided.
|
|
| domain | founded_year | HQ Location |
Genomic database for clinical research is provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| domain | founded_year | HQ Location |
Data analysis and statistical solutions are provided for life sciences.
|
|
| domain | founded_year | HQ Location |
AI-based omics data analysis solutions are provided to researchers.
|
|
| domain | founded_year | HQ Location |
Developer of predictive informatics based platform for drug discovery
|
Frequently Asked Questions about Xbiome
Xbiome was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Xbiome is headquartered in Shenzhen, China. It is registered at Shenzhen, Guangdong, China.
Xbiome is a funded company, having raised a total of $107.5M across 5 funding rounds to date.
Xbiome was founded in 2017 in Shenzhen, China, within the biotechnology sector. An AI-enabled bioinformatics platform is utilized by the company to identify drugs based on the intestinal microbiome. Fecal microbiota transplantation (FMT) technology is employed for drug development targeting multiple diseases. Microbiota from healthy donors stool is extracted through established methods and transplanted into patients for therapeutic purposes across various conditions.
Xbiome has 10 investors. Key investors include Primavera Capital Group, Gaorong Capital, Legend Capital, Sky9 Capital, and 5Y Capital.